The legal battle between tech giant Apple and Masimo, a medical device manufacturer, has been going on for years. The case was brought to court over allegations of patent infringement, with Masimo accusing Apple of stealing its technology to create the Apple Watch. The lawsuit has been closely watched by both the tech and medical industries, as it could have far-reaching implications for both.

Recently, the jury for the case was unable to reach a verdict, leaving the outcome of the trial in limbo. The case was heard in the U.S. District Court for the Central District of California, and both companies presented their arguments over the course of several weeks.

Masimo claims that Apple stole its technology for measuring blood oxygen levels, which is a key feature of the Apple Watch. According to Masimo, Apple had originally entered into discussions with the company over a potential partnership, but ultimately used the information gained from those talks to develop its own technology.

Apple has denied these claims, arguing that it developed its own technology independently. The company also pointed out that the patents in question were invalid, as they were based on existing technology that had been in use for years.

The case has been closely watched by industry insiders, as the outcome could have major implications for the future of wearable technology. If Masimo wins the case, it could set a precedent for medical device manufacturers to pursue legal action against tech companies that use their technology without permission.

On the other hand, if Apple wins the case, it could provide a boost to the company’s efforts to expand into the health and wellness space. The Apple Watch has become an increasingly important part of Apple’s business in recent years, with the company touting its health and fitness features as key selling points.

While the outcome of the trial remains uncertain, both Apple and Masimo have stated that they will continue to pursue legal action if necessary. The case highlights the ongoing tension between the tech and medical industries, as companies increasingly look to integrate medical technology into their products and services.

The legal battle also raises questions about the role of patents in technology innovation. While patents are meant to protect intellectual property, some argue that they can stifle innovation by limiting the ability of others to build upon existing technology.

Regardless of the outcome, the Apple-Masimo legal battle will have far-reaching implications for the tech and medical industries. As companies continue to develop new products and services that blur the lines between these two fields, the issue of intellectual property and patent infringement is likely to remain a contentious one.